Identifying the genetic basis of variably protease-sensitive prionopathy

NIH RePORTER · NIH · R03 · $66,800 · view on reporter.nih.gov ↗

Abstract

PROJECT SUMMARY First characterized one decade ago, VPSPr is a rare neurodegenerative disease that presents clinically as Lewy body dementia or frontotemporal lobar degeneration but has been neuropathologically linked to deposits of infectious but protease-sensitive prion protein (PrP) aggregates. VPSPr cases lack mutations in the prion protein gene (PRNP) but 42% of cases have a positive family history, consistent with a genetic disease of moderate penetrance. We will apply whole exome sequencing and deep targeted sequencing to query the genetic basis of VPSPr. Identification of a genetic cause of VPSPr will aid in the differential diagnosis of prion disease and Alzheimer’s-related dementias, validate new genomic technologies for understanding neurodegeneration, and identify new cellular pathways that lead to neurodegenerative disease.

Key facts

NIH application ID
10448659
Project number
1R03NS123786-01A1
Recipient
BROAD INSTITUTE, INC.
Principal Investigator
Eric Vallabh Minikel
Activity code
R03
Funding institute
NIH
Fiscal year
2022
Award amount
$66,800
Award type
1
Project period
2022-02-01 → 2023-01-31